Track the Biotage AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Biotage AB has logged 9 reports. The latest transaction was reported on 22 July 2025 (Purchase). Among the most active insiders: Kugan Sathiyanandarajah. All data is openly available.
9
Insider Decl.
n/a
Thresholds
€974m
5 ops.
Buy Volume
€177m
4 ops.
Sell Volume
15Σ signal
Buys €974m€177m Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
42,000 shares@ €12.995562.7% of flowAktieFI:A003P087-1
9 of 9 declarations
About Biotage AB
Biotage AB is a Swedish company focused on developing solutions for the purification and analysis of chemical compounds. It primarily operates in the healthcare and pharmaceutical sector, listed on the Stockholm Stock Exchange.